NO20004980L - Particulate articles of active ingredients for pulmonary use - Google Patents

Particulate articles of active ingredients for pulmonary use

Info

Publication number
NO20004980L
NO20004980L NO20004980A NO20004980A NO20004980L NO 20004980 L NO20004980 L NO 20004980L NO 20004980 A NO20004980 A NO 20004980A NO 20004980 A NO20004980 A NO 20004980A NO 20004980 L NO20004980 L NO 20004980L
Authority
NO
Norway
Prior art keywords
active ingredients
particulate
pulmonary use
particulate articles
pulmonary
Prior art date
Application number
NO20004980A
Other languages
Norwegian (no)
Other versions
NO20004980D0 (en
Inventor
Holger Bengs
Juergen Grande
Original Assignee
Axiva Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axiva Gmbh filed Critical Axiva Gmbh
Publication of NO20004980D0 publication Critical patent/NO20004980D0/en
Publication of NO20004980L publication Critical patent/NO20004980L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)

Abstract

Oppfinnelsen angår tilveiebringelse av en partikulær virkestoffbærer og dens farmasøytiske sammensetning med depotvirkning for pulmonal applikasjon. Den tønformulerbare biokompatible, partikulære virkestoffbæreren fremstilles helt eller til dels av lineære vannuoppløselige polysakkarider, fortrinnsvis poly(l,4-a-D-glukan), med homogen enhetlig størrelse fra fortrinnsvis biotransformatorisk fremstilling med evnen til å kluster- og/eller agglomeratdannelse. De derav resulterende fordeler benyttes fortrinnsvis i rammen av den tørre pulverinhaleringen.The invention relates to the provision of a particulate active substance and its pharmaceutical composition with depot effect for pulmonary application. The barrel-formulated biocompatible particulate carrier is prepared wholly or in part by linear water-insoluble polysaccharides, preferably poly (1,4-a-D-glucan), of homogeneous uniform size, preferably from biotransformational preparation with the ability to cluster and / or agglomerate formation. The resulting advantages are preferably used in the frame of the dry powder inhalation.

NO20004980A 1998-04-09 2000-10-03 Particulate articles of active ingredients for pulmonary use NO20004980L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19816085 1998-04-09
PCT/EP1999/002385 WO1999052506A1 (en) 1998-04-09 1999-04-08 Particulate active agent support for pulmonary application

Publications (2)

Publication Number Publication Date
NO20004980D0 NO20004980D0 (en) 2000-10-03
NO20004980L true NO20004980L (en) 2000-12-08

Family

ID=7864224

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004980A NO20004980L (en) 1998-04-09 2000-10-03 Particulate articles of active ingredients for pulmonary use

Country Status (12)

Country Link
EP (1) EP1069889B1 (en)
JP (1) JP2002511399A (en)
KR (1) KR20010034755A (en)
CN (1) CN1423553A (en)
AT (1) ATE270097T1 (en)
AU (1) AU3421099A (en)
CA (1) CA2340340A1 (en)
DE (1) DE59909854D1 (en)
HU (1) HUP0101912A2 (en)
NO (1) NO20004980L (en)
PL (1) PL343342A1 (en)
WO (1) WO1999052506A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19847593A1 (en) * 1998-10-15 2000-04-20 Aventis Res & Tech Gmbh & Co Parenteral drug administration composition with depot and controlled release comprises active agent and water soluble polysaccharide microparticles as carrier
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
ES2395096T3 (en) * 1999-06-29 2013-02-08 Mannkind Corporation Purification and stabilization of pharmaceutical agents based on peptides and proteins
WO2003080149A2 (en) 2002-03-20 2003-10-02 Mannkind Corporation Inhalation apparatus
US20080090753A1 (en) 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
ATE486064T1 (en) 2004-08-20 2010-11-15 Mannkind Corp CATALYSIS OF DIKETOPIPERAZINE SYNTHESIS
HUE025151T2 (en) 2004-08-23 2016-01-28 Mannkind Corp Diketopiperazine salts for drug delivery
KR101486397B1 (en) 2005-09-14 2015-01-28 맨카인드 코포레이션 Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US8084420B2 (en) 2005-09-29 2011-12-27 Biodel Inc. Rapid acting and long acting insulin combination formulations
KR20080096809A (en) * 2006-02-22 2008-11-03 맨카인드 코포레이션 Method for Improving Pharmaceutical Properties of Microparticles Containing Diketopiperazine and Active Agents
ES2929343T3 (en) 2008-06-13 2022-11-28 Mannkind Corp Suction Actuated Dry Powder Inhaler for Drug Delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
MX2010014240A (en) 2008-06-20 2011-03-25 Mankind Corp An interactive apparatus and method for real-time profiling of inhalation efforts.
TWI494123B (en) 2008-08-11 2015-08-01 Mannkind Corp Ultra-fast use of insulin
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
WO2010105094A1 (en) 2009-03-11 2010-09-16 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
MY157166A (en) 2009-06-12 2016-05-13 Mankind Corp Diketopiperazine microparticles with defined specific surface areas
US8227409B2 (en) 2009-06-12 2012-07-24 Mannkind Corporation Diketopiperazine microparticles with defined isomer contents
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
BR112012033060A2 (en) 2010-06-21 2018-02-27 Mannkind Corp Dry powder drug release system methods
AU2012236150B2 (en) 2011-04-01 2016-03-31 Mannkind Corporation Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
BR112014009686A2 (en) 2011-10-24 2018-08-07 Mannkind Corp Inhalable analgesic composition, dry powder and method for treating pain
AU2013289957B2 (en) 2012-07-12 2017-02-23 Mannkind Corporation Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
BR112015010601B1 (en) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOSITION
KR102246914B1 (en) 2013-03-15 2021-04-30 맨카인드 코포레이션 Microcrystalline diketopiperazine compositions and methods
CN114848614A (en) 2013-07-18 2022-08-05 曼金德公司 Thermally stable dry powder pharmaceutical compositions and methods
EP3030294B1 (en) 2013-08-05 2020-10-07 MannKind Corporation Insufflation apparatus
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
WO2018222581A1 (en) * 2017-05-29 2018-12-06 Resinnate Therapeutics Llc Methods and formulations for administering beta glucan

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB937303A (en) * 1959-01-02 1963-09-18 Benger Lab Ltd Improvements in and relating to the application of drugs in finely divided condition
US6428771B1 (en) * 1995-05-15 2002-08-06 Pharmaceutical Discovery Corporation Method for drug delivery to the pulmonary system
GB9606188D0 (en) * 1996-03-23 1996-05-29 Danbiosyst Uk Pollysaccharide microspheres for the pulmonary delivery of drugs
DE19737481A1 (en) * 1997-08-28 1999-03-04 Hoechst Ag Microparticles containing spherical linear polysaccharides

Also Published As

Publication number Publication date
AU3421099A (en) 1999-11-01
ATE270097T1 (en) 2004-07-15
WO1999052506A1 (en) 1999-10-21
JP2002511399A (en) 2002-04-16
CN1423553A (en) 2003-06-11
DE59909854D1 (en) 2004-08-05
CA2340340A1 (en) 1999-10-21
WO1999052506B1 (en) 1999-11-25
NO20004980D0 (en) 2000-10-03
EP1069889B1 (en) 2004-06-30
EP1069889A1 (en) 2001-01-24
HUP0101912A2 (en) 2001-10-28
KR20010034755A (en) 2001-04-25
PL343342A1 (en) 2001-08-13

Similar Documents

Publication Publication Date Title
NO20004980L (en) Particulate articles of active ingredients for pulmonary use
CN100543427C (en) calcium carbonate particles
RU2008112146A (en) COMPOSITIONS AND METHODS FOR PRODUCING MEDICINAL PRODUCTS Slightly Soluble in Water with Increased Stability
DK1441704T3 (en) Orodispersible tablet with high homogeneity and process for its preparation
MY129282A (en) Aerosolizable particles resistant to hygroscopic growth
ATE73472T1 (en) PROCESS FOR MANUFACTURE OF A CONTROLLED DELIVERY SYSTEM FOR CALCIUM.
MY139606A (en) Sustained-release composition and process for producing the same
DK486189D0 (en) PSYLLIUM FRESH CALLS AND AGENTS COMPREHENSIVE TOGETHER
Bowyer Osteophagia and antler breakage among Roosevelt elk.
KR100740370B1 (en) Composition comprising ascorbic acid and pectin
WO2005084703A1 (en) Sustained-release composition for oral cavity
JPH0651628B2 (en) Nutritional composition
CN113081893A (en) Oral bacteriostatic composition, preparation method and application thereof
KR101861658B1 (en) Gel composition comprising mineral
BRPI0212195B1 (en) COMPOSITIONS CONTAINING PECTIN AND ASCORBIC ACID
RU97114578A (en) BIOLOGICALLY ACTIVE CORRIDA FOOD ADDITIVES
JPS62228272A (en) Stable peroxidase formulation
JPH06247860A (en) Iron absorption promoter comprising decomposition product of guar gum with enzyme as active ingredient
JP2616822B2 (en) Calcium preparation
JP7429076B1 (en) Powder containing lactic acid bacteria, disinfectant, oral care agent
JP2602712B2 (en) Heme iron-containing composition
CN109620841A (en) A kind of arabogalactan base nanometer selenium and its preparation method and application
JP2000245374A (en) Noodles having improved quality, production thereof, and quality improver
JPS6318458B2 (en)
JPH0759182B2 (en) Food preservatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application